Medicine & Life Sciences
Pulmonary Arterial Hypertension
76%
Epoprostenol
73%
Drug Delivery Systems
63%
Nanoparticles
57%
Endothelin Receptor Antagonists
28%
Phosphodiesterase 5 Inhibitors
28%
Pharmaceutical Preparations
17%
pitavastatin
16%
fasudil
16%
Synthetic Prostaglandins
14%
Critical Pathways
12%
Endothelins
12%
Imatinib Mesylate
12%
Medication Adherence
11%
Sirolimus
11%
Oligonucleotides
11%
Therapeutics
10%
Patient Compliance
10%
Nitric Oxide
8%
Clinical Studies
7%
Aptitude
7%
Safety
6%
Survival
5%
Animals
5%
In Vitro Techniques
4%
Physics & Astronomy
hypertension
100%
drugs
65%
delivery
61%
prostaglandins
54%
nanoparticles
43%
inhibitors
25%
pathogenesis
16%
oligonucleotides
15%
nitric oxide
13%
progressions
12%
animals
10%
safety
10%
analogs
8%
Chemical Compounds
Prostaglandin I2
83%
Endothelin Receptor Antagonist
55%
Phosphodiesterase V Inhibitor
50%
Drug
34%
Nanoparticle
32%
Pitavastatin
29%
Imatinib
24%
Nitric Oxide
15%
Safety
13%
Engineering & Materials Science
Drug Delivery Systems
95%
Nanoparticles
63%
Oligonucleotides
24%
Nitric oxide
22%
Drug delivery
21%
Animals
15%